cilostazol has been researched along with mdl 100907 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nagai, H; Nakagawa, H; Niki, H; Nishikawa, M; Yamada, K | 1 |
1 other study(ies) available for cilostazol and mdl 100907
Article | Year |
---|---|
Serotonin potentiates high-glucose-induced endothelial injury: the role of serotonin and 5-HT(2A) receptors in promoting thrombosis in diabetes.
Topics: Animals; Aspirin; Cells, Cultured; Cilostazol; Diabetes Mellitus, Experimental; Fibrinolytic Agents; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Male; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Succinates; Tetrazoles; Thrombosis; Vascular Cell Adhesion Molecule-1 | 2012 |